Premier Inc. and 11 Leading Health Systems Invest in Exela Pharma Sciences to Secure and Support U.S.-Based Drug Supply and Manufacturing
Similar Posts
Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines
Curevo’s lead program is CRV-101, an adjuvanted subunit vaccine for shingles, which has demonstrated robust immunogenicity and tolerability in…
Olive signs partnership agreement with Amend Health
Partnership to accelerate the introduction of digital health solutions through the Olive Helps platform. Olive and Amend Health signed…
ACU-Serve Acquires TANYR to Broaden Post-Acute RCM Capabilities
ACU-Serve Acquires TANYR, Strengthens Position in Post-Acute RCM Market ACU-Serve has announced the acquisition of TANYR, a company specializing…
